Jennifer Lee

Jennifer Lee is a seasoned professional in clinical operations, currently serving as the Senior Director of Clinical Operations at A2 Biotherapeutics, Inc. since January 2025. Prior roles include Senior Director and Director of Clinical Operations at Neogene Therapeutics, and Associate Director at Kite Pharma, where significant responsibilities encompassed overseeing clinical trial conduct, managing vendor relationships, and ensuring site quality. Jennifer has a solid background in managing clinical studies across various therapeutic areas, including type 1 diabetes mellitus and myocardial infarction, and has consistently achieved key milestones, such as patient enrollment and database locks. With a Bachelor of Science in Exercise Biology from the University of California, Davis, Jennifer has developed a diverse skill set in clinical project management and vendor oversight since beginning the career in 2006.